The Chemours Company

NYSE:CC

Chemicals - Specialty

Basic Materials
$12.09 -1.20%

-$0.27 today

Market cap
$1.82B
Beta
1.39
P/E (TTM)
-8.0
EPS (TTM)
-$2.73
Dividend yield
1.61%
52W Low $10.14High $28.67

Volume 2.86M

Average 2.80M

CC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

The Chemours CompanyNYSE: CC

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development declines year over year

Q2 FY2026 research & development of $27M fell 3.6% year over year, in line with the -3.6% change in trailing-twelve-month research & development. Sequentially, it rose 3.8% from the prior quarter. Over 3 fiscal years it compounded at -2.9% a year.

Context

  • Research & development amounted to 1.9% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -3.6% holds above the trailing-twelve-month pace of -3.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$27M+3.8% QoQ
Last fiscal yearDec 2025
$108M-0.9% YoY
LTMJun 2026
$106M-3.6% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.6%——
1 year-0.9%——
3-year CAGR-2.9%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
108M USD
Year-over-year change
-0.9%
4-year CAGR
+0.2%

Research & Development vs competitors

How CC compares with its peers on the latest reported figures

  • CC's LTM Jun 2026 research & development of $106M is the 5th highest of the 19 companies compared; the peer median is $41.6M.
  • Its year-over-year change of -3.6% is the 7th highest of 13, against a peer median of -2.7%.
  • Research & development amounts to 1.8% of revenue for CC, versus a peer median of 0.6%.
CC Competitors Peer median
Research & Development for CC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IFFInternational Flavors & Fragrances Inc.LTM Jun 2026$684M +0.9%+4.8%6.9%
PPGPPG Industries, Inc.LTM Jun 2026$435M +5.8%-0.9%2.6%
LINLinde plcLTM Jun 2026$146M -3.9%+0.9%0.4%
LYBLyondellBasell Industries N.V.LTM Sep 2026$140M -1.4%+3.6%0.4%
CCThe Chemours CompanyLTM Jun 2026$106M -3.6%-2.9%1.8%
APDAir Products and Chemicals, Inc.LTM Sep 2026$88.9M -7.7%-5.6%0.7%
ESIElement Solutions IncLTM Sep 2026$80M +23.8%+11.5%2.3%
AXTAAxalta Coating Systems Ltd.LTM Jun 2026$70M -6.7%+2.5%1.4%
CBTCabot CorporationLTM Jun 2026$55M -9.8%+2.4%1.5%
ASHAshland Inc.LTM Jun 2026$55M +3.8%-0.6%3.0%
OECOrion Engineered Carbons S.A.LTM Mar 2026$28.2M +4.1%+8.2%1.6%
FFFutureFuel Corp.LTM Mar 2026$3.32M -26.0%+4.2%3.0%
WLKWestlake CorporationLTM Sep 2026$0 ——0.0%
SXTSensient Technologies CorporationLTM Jun 2026$0 ——0.0%
PRMPerimeter Solutions, Inc.LTM Jun 2026$0 ——0.0%
KWRQuaker Chemical CorporationLTM Sep 2026$0 ——0.0%
FULH.B. Fuller CompanyLTM Aug 2026$0 -100.0%—0.0%
WTTRSelect Water Solutions, Inc.LTM Sep 2026$0 ——0.0%
ECVTEcovyst Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding CC) $41.6M-2.7%+2.5%0.6%

Competitors are the stored peer set for CC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.35B6.83B6.08B5.78B5.81B
Cost of Revenue4.96B5.22B4.77B4.63B4.91B
Gross Profit1.38B1.62B1.31B1.15B902M
Gross Margin21.8%23.7%21.5%19.9%15.5%
Research & Development107M118M108M109M108M
Selling, General & Admin592M710M1.29B585M799M
Operating Expenses707M830M1.43B708M907M
Depreciation & Amortization317M291M307M301M340M
EBITDA1.18B1.2B197M692M332M
EBITDA Margin18.6%17.5%3.2%12.0%5.7%
Operating Income674M786M(123M)443M(5M)
Operating Margin10.6%11.5%-2.0%7.7%-0.1%
Interest Income00000
Interest Expense185M163M208M264M269M
Other Income / Expenses2M(45M)(195M)(316M)(272M)
Income Before Tax676M741M(318M)127M(277M)
Pre-Tax Margin10.7%10.8%-5.2%2.2%-4.8%
Income Tax Expense68M163M(81M)41M109M
Net Income608M578M(238M)86M(386M)
Net Margin9.6%8.5%-3.9%1.5%-6.6%
EPS (Basic)3.693.72(1.60)0.58(2.57)
EPS (Diluted)3.603.65(1.60)0.57(2.56)
Weighted Avg Shares164.94M155.36M148.91M149.49M150.35M
Weighted Avg Shares (Diluted)168.7M158.3M148.91M150.01M150.55M

The Chemours Company

NYSE:CC

Intrinsic Alpha fair value

Locked

Current Price

$12.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.